Management of Hypoxemia and Tissue Hypoxia

Definitions and Pathophysiology

Hypoxemia refers specifically to low partial pressure of oxygen or low oxygen content in the blood, with various definitions including SaO₂ <94%, <92%, <90%, or PaO₂ <60 mmHg, as defined by the Thorax journal 1.
Hypoxia is a broader term referring to insufficient oxygen supply to meet metabolic demands at the tissue level, occurring when oxygen delivery to tissues is inadequate, regardless of blood oxygen levels, as stated by the Thorax journal 1, 2.
Tissue hypoxia can be subdivided into four main causes, including hypoxemic hypoxia, anemic hypoxia due to reduced hemoglobin capacity to carry oxygen 1, stagnant hypoxia, and histotoxic hypoxia due to inability of tissues to utilize oxygen, such as in cyanide poisoning 2.

Oxygen therapy is the primary treatment for hypoxemia, with target oxygen saturation should be ≥94% for most acutely hypoxemic patients, as recommended by the Thorax journal 1, 3.
For patients with COPD or risk of hypercapnic respiratory failure, target saturation should be 88-92%, according to the Thorax journal 1.
Delivery methods should be selected based on severity, with non-invasive ventilation for moderate-severe hypoxemia with increased work of breathing 5.
Monitoring during oxygen therapy is essential, with regular pulse oximetry to ensure target saturation is maintained 3, 4.

Treatment of tissue hypoxia depends on the underlying mechanism, with oxygen therapy as described above for hypoxemic hypoxia 1.
For anemic hypoxia, blood transfusion may be indicated for severe anemia, with a consideration threshold of hemoglobin <70 g/L in critically ill patients 4.
For stagnant hypoxia, improving cardiac output with fluids, inotropes, or vasopressors as indicated, and treating underlying causes such as heart failure or shock, is recommended by the Intensive Care Medicine journal 3, 4.
For histotoxic hypoxia, specific antidotes, such as for cyanide poisoning, and supportive care, including treatment of underlying sepsis if mitochondrial dysfunction is suspected, are necessary 2, 3.

For hypoxemia, pulse oximetry and arterial blood gas analysis are used for monitoring, with respiratory rate and pattern also being assessed 3, 5.
For tissue hypoxia, clinical signs of inadequate tissue oxygenation, lactate levels, and mixed venous oxygen saturation or central venous oxygen saturation are used for monitoring 3, 4.

Normal oxygen saturation does not rule out tissue hypoxia, as patients with adequate SpO₂ may still have tissue hypoxia due to anemic, stagnant, or histotoxic mechanisms, as stated by the Thorax journal 1.
Hyperoxia can be harmful, causing oxygen toxicity, absorption atelectasis, and worsening hypercapnia in some conditions, such as COPD, according to the Critical Care journal 5, 6.
Delayed recognition of non-hypoxemic causes of tissue hypoxia can lead to inappropriate management focused solely on oxygen therapy when other interventions are needed, as warned by the Thorax journal 1.
Failure to recognize deterioration during non-invasive support can result in delayed intubation and worse outcomes, emphasizing the importance of close monitoring when using non-invasive ventilation, as recommended by the Critical Care journal 5.